Susceptibility testing of Haemophilus influenzae to clarithromycin | Zendy

R. Paton | Zendy; Jorge Arnold | Zendy; J. Cockburn | Zendy; F.X.S. Emmanuel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Susceptibility testing of Haemophilus influenzae to clarithromycin

Author(s) -

R. Paton,

Jorge Arnold,

J. Cockburn,

F.X.S. Emmanuel

Publication year - 2000

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/45.4.529

Subject(s) - haemophilus influenzae , clarithromycin , microbiology and biotechnology , macrolide antibiotics , antibacterial agent , antibiotics , medicine , biology , erythromycin

Susceptibility testing of Haemophilus influenzae to the macrolide compounds has often been problematic. This is as a result of the inability of many isolates of H. influenzae to grow without the addition of 5% CO2 to the incubation atmosphere and the subsequent detrimental effect that CO2 has on the activity of the macrolide group of compounds. This report describes refinements and recommendations for susceptibility testing of H. influenzae to the macrolide clarithromycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research